
Mirodenafil
Mirodenafil has been used in trials studying the treatment and supportive care of Kidney Diseases, Urologic Diseases, Renal Insufficiency, Erectile Dysfunction, and Male Erectile Dysfunction. — DrugBank
- IUPAC name
- 5-ethyl-2-[5-[4-(2-hydroxyethyl)piperazin-1-yl]sulfonyl-2-propoxyphenyl]-7-propyl-3H-pyrrolo[3,2-d]pyrimidin-4-one
- Molecular formula
- C26H37N5O5S
- Molecular weight
- 531.7 g/mol
- Exact mass
- 531.25154047 Da
- XLogP3
- 2.2
- Topological polar surface area
- 125.0 Ų
- Hydrogen-bond donors
- 2
- Hydrogen-bond acceptors
- 8
- Covalent units
- 1
- Defined stereocentres
- 0
Also known as
16 more reported names
External database identifiers
- ChEBI:CHEBI:136049
- ChEMBL:CHEMBL4297518
- EPA DTXSID:DTXSID50881265
- PubMed:33987996
- PubMed:24872948
- PubMed:22921287
- PubMed:22692776
- PubMed:22654729
- PubMed:22259736
- PubMed:22087063
- PubMed:21905762
- PubMed:21814227
- PubMed:21790657
- PubMed:21585174
- PubMed:21478894
Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.